Asymmetric total synthesis of (+)-crassalactone D

Journal of Organic Chemistry

Volumn 74, Issue 24, 2009, Pages 9546-9549

  Yang, Zhicai ^a   Tang, Phung ^a   Gauuan, Jolicia F ^a   Molino, Bruce F ^a  

^a ALBANY MOLECULAR RESEARCH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-TUMOR AGENTS; ASYMMETRIC TOTAL SYNTHESIS; CHEMICAL EQUATIONS; NATURALLY OCCURRING; SPIROCYCLIZATION;

CHEMICAL REACTIONS;

5 EPI 7 EPI CRASSALACTONE D; 7 EPICRASSALACTONE D; ANTINEOPLASTIC AGENT; CRASSALACTONE D; FURAN DERIVATIVE; LACTONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; ASYMMETRIC SYNTHESIS; CANCER CHEMOTHERAPY; CYCLIZATION; DRUG STRUCTURE; DRUG SYNTHESIS; OXIDATION; PROTON NUCLEAR MAGNETIC RESONANCE; X RAY CRYSTALLOGRAPHY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CYCLIZATION; FURANS; SPIRO COMPOUNDS; STEREOISOMERISM;

EID: 73149083971     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo902055b     Document Type: Article

References (24)

1. Tuchinda, P.; Munyoo, B.; Pohmakotr, M.; Thinapong, P.; Sophasan, S.; Santisuk, T.; Reutrakul, V. J. Nat. Prod. 2006, 69, 1728-1733.
2. (a) Popsavin, V.; Benedekovic, G.; Sreco, B.; Popsavin, M.; Francuz, J.; Kojic, V.; Bogdanoviv, G. Org. Lett. 2007, 9, 4235-4238.
3. (b) Popsavin, V.; Benedekovic, G.; Sreco, B.; Popsavin, M.; Francuz, J.; Kojic, V.; Bogdanoviv, G. Bioorg. Med. Chem. Lett. 2008, 18, 5178-5181.
4. Pavlakos, E.; Georgiou, T.; Tofi, M.; Montagnon, T.; Vassilikogiannakis, G. Org. Lett. 2009, 11, 4556-4559.
5. (a) Robertson, J.; Meo, P.; Dallimore, J. W. P.; Doyle, B. M.; Hoarau, C. Org. Lett. 2004, 6, 3861-3863.
6. (b) Robertson, J.; Stevens, K.; Naud, S. Synlett 2008, 14, 2083-2086.
7. Sharpless, K. B.; Amberg, W.; Bennani, Y. L.; Crispino, G. A.; Hartung, J.; Jeong, K. S.; Kwong, H. L.; Morikawa, K.; Wang, Z. M.; Xu, D.; Zhang, X.-L. J. Org. Chem. 1992, 57, 2768-2771.
8. Wang, L.; Sharpless, K. B. J. Am. Chem. Soc. 1992, 114, 7568-7570.
9. Zhang, S.; Marshell, D.; Liebeskind, L. S. J. Org. Chem. 1999, 64, 2796-2804.
10. The ee value was determined by chiral HPLC on a Chiralcel OJ-H column (250 x 4.6 mm) by comparison to the corresponding (±)-11. See the Supporting Information for the preparation of (±)-11.
11. (a) McDermott, P. J.; Stockman, R. A. Org. Lett. 2005, 7, 27-29.
12. (b) Krishna, U. M.; Srikanth, G. S. C.; Trivedi, G. K. Tetrahedron Lett. 2003, 44, 8227-8228.
13. (c) Harris, J. M.; O'Doherty, G. A. Org. Lett. 2000, 2, 2983-2986.
14. (d) Grapsas, I.; Couladouros, E. A.; Georgiadis, M. P. Pol. J. Chem. 1990, 64, 823.
15. (e) Georgiadis, M. P.; Couladouros, E. A. J. Org. Chem. 1986, 51, 2725-2727.
16. (a) Fukuda, H.; Takeda, M.; Sato, Y.; Mitsunobu, O. Synthesis 1979, 5, 368-370.
17. (b) Montagnon, T.; Tofi, M.; Vassilikogiannakis, G. Acc. Chem. Res. 2008, 41, 1001-1011.
18. (a) Wu, H.-J.; Lin, C.-C. J. Org. Chem. 1996, 61, 3820-3828.
19. (b) Laliberte, R.; Medawar, G.; Lefebvre, Y. J. Med. Chem. 1973, 16, 1084-1089.
20. (c) Lefebvre, Y. Tetrahedron Lett. 1972, 133-136.
21. (a) Varasi, M.; Walker, K. A. M.; Maddox, M. L. J. Org. Chem. 1987, 52, 4235-4238.
22. (b) Stork, G.; West, F.; Lee, H. Y.; Isaacs, R. C. A.; Manabe, S. J. Am. Chem. Soc. 1996, 118, 10660-10661.
23. 30D reported in ref 1. A similar result was obtained for synthetic (+)-crassalactone C reported in ref 2a.
24. See the Supporting Information for more details.